Over the last 7 days, the Biotech industry has remained flat, although notably AbbVie gained 3.0%. As for the the longer term, the industry is up 9.8% over the past 12 months. Earnings are forecast to grow by 30% annually.
Has the U.S. Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Mon, 12 Aug 2024 | US$862.3b | US$112.7b | -US$36,815,169,721.78 | 21.6x | -23.4x | 7.7x |
Wed, 10 Jul 2024 | US$1.1t | US$164.5b | -US$28,071,564,685.96 | 28.5x | -40.7x | 6.9x |
Fri, 07 Jun 2024 | US$1.2t | US$164.6b | -US$26,702,448,993.85 | 28x | -43.3x | 7x |
Sun, 05 May 2024 | US$1.1t | US$163.7b | -US$26,731,775,868.34 | 24.3x | -42x | 6.9x |
Tue, 02 Apr 2024 | US$1.2t | US$164.5b | -US$23,680,262,586.04 | 24.1x | -49.8x | 7.2x |
Thu, 29 Feb 2024 | US$1.2t | US$167.4b | -US$21,465,686,557.06 | 13.4x | -56.3x | 7.2x |
Sat, 27 Jan 2024 | US$1.4t | US$204.7b | -US$22,646,483,045.00 | 18.3x | -63.4x | 7x |
Mon, 25 Dec 2023 | US$1.4t | US$204.9b | -US$22,149,017,627.00 | 19.4x | -61.9x | 6.7x |
Wed, 22 Nov 2023 | US$1.2t | US$204.7b | -US$22,046,246,661.00 | 18.1x | -55.4x | 6x |
Fri, 20 Oct 2023 | US$1.2t | US$207.4b | -US$13,089,607,875.00 | 16.6x | -93.9x | 5.9x |
Sun, 17 Sep 2023 | US$1.3t | US$207.5b | -US$12,865,929,372.00 | 17.5x | -99.8x | 6.2x |
Tue, 15 Aug 2023 | US$1.3t | US$207.7b | -US$12,584,014,109.00 | 16.6x | -102.4x | 6.2x |
Thu, 13 Jul 2023 | US$1.1t | US$186.5b | -US$15,948,766,717.00 | 13.2x | -70.8x | 6.1x |
Sat, 10 Jun 2023 | US$1.1t | US$186.0b | -US$15,970,598,297.00 | 11.7x | -71.6x | 6.1x |
Mon, 08 May 2023 | US$1.2t | US$192.6b | -US$12,085,119,722.00 | 15.6x | -97.1x | 6.1x |
Wed, 05 Apr 2023 | US$1.2t | US$216.9b | -US$5,746,040,908.00 | 14.5x | -200.5x | 5.3x |
Fri, 03 Mar 2023 | US$1.1t | US$199.0b | -US$5,026,926,227.00 | 15.3x | -226x | 5.7x |
Sun, 29 Jan 2023 | US$1.2t | US$203.8b | US$1.8b | 14.8x | 668.9x | 5.7x |
Tue, 27 Dec 2022 | US$1.2t | US$203.3b | US$1.6b | 14.5x | 703x | 5.7x |
Thu, 24 Nov 2022 | US$1.1t | US$202.3b | US$1.3b | 14.6x | 868.7x | 5.6x |
Sat, 22 Oct 2022 | US$1.1t | US$206.2b | US$5.3b | 15.8x | 200.9x | 5.2x |
Mon, 19 Sep 2022 | US$1.1t | US$206.6b | US$5.9b | 14.7x | 182.2x | 5.2x |
Wed, 17 Aug 2022 | US$1.1t | US$206.6b | US$7.2b | 16.4x | 155.4x | 5.4x |
Fri, 15 Jul 2022 | US$1.1t | US$211.1b | US$10.6b | 16.9x | 101x | 5.1x |
Sun, 12 Jun 2022 | US$957.4b | US$212.3b | US$11.1b | 15.6x | 86.5x | 4.5x |
Tue, 10 May 2022 | US$971.1b | US$207.6b | US$9.6b | 13.5x | 100.7x | 4.7x |
Thu, 07 Apr 2022 | US$1.3t | US$226.8b | US$14.3b | 18.6x | 90.8x | 5.7x |
Sat, 05 Mar 2022 | US$1.2t | US$221.9b | US$10.2b | 18.9x | 117.5x | 5.4x |
Mon, 31 Jan 2022 | US$1.2t | US$212.2b | US$2.5b | 23x | 495.5x | 5.8x |
Wed, 29 Dec 2021 | US$1.4t | US$212.0b | US$2.8b | 25.9x | 512.4x | 6.7x |
Fri, 26 Nov 2021 | US$1.4t | US$211.8b | US$3.1b | 25.7x | 466x | 6.8x |
Sun, 24 Oct 2021 | US$1.5t | US$196.3b | -US$2,790,790,019.00 | 24x | -530.3x | 7.5x |
Tue, 21 Sep 2021 | US$1.6t | US$196.3b | -US$2,228,287,219.00 | 25.2x | -715.8x | 8.1x |
Thu, 19 Aug 2021 | US$1.5t | US$197.0b | -US$1,662,914,785.58 | 22.2x | -909.9x | 7.7x |
-909.9x
Which industries have driven the changes within the U.S. Healthcare industry?
US Market | 2.60% | |
Healthcare | 2.00% | |
Biotech | -0.31% | |
Biotech | -0.31% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
ABBV AbbVie | US$189.93 | 3.0% +US$9.9b | 24.7% | PE63.3x | |
REGN Regeneron Pharmaceuticals | US$1.13k | 5.6% +US$6.5b | 39.9% | PE28.3x | |
NTRA Natera | US$114.57 | 17.0% +US$2.1b | 101.3% | PS10.4x | |
SGEN Seagen | US$228.74 | 4.5% +US$1.8b | 76.5% | PS18.8x | |
BGNE BeiGene | US$182.76 | 10.3% +US$1.8b | -10.5% | PS6.3x |